Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cambridge, Massachusetts
- Most recent report
- 10-Q, filed Sep 8, 2026
- Incorporated
- Delaware
- Filings on record
- 54 filings
- On EDGAR
- CIK 1745648
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
Financials 1
News 2
Prospectuses and Registrations 5
Ownership 8 of 23
- SCHEDULE 13G Large holder reported a passive stake Aug 7, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 6, 2026
- 4 Insider reported a trade Aug 5, 2026
- 4 Insider reported a trade Aug 5, 2026
- 4 Insider reported a trade Aug 3, 2026
- 4 Insider reported a trade Aug 3, 2026
- 4 Insider reported a trade Aug 3, 2026
- 4 Insider reported a trade Aug 3, 2026
Other 8 of 23
- EFFECT Notice that a registration became effective Jul 30, 2026
- S-1MEF Jul 30, 2026
- CERT Exchange certified a listing Jul 30, 2026
- 8-A12B Registration of a security for exchange listing Jul 29, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Jun 1, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Apr 22, 2026
- D Mar 27, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Feb 17, 2026
Everything here comes from Apnimed, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.